| Section | Title | Authors | Address |
|---|
|
| Genes | ABL1 (v-abl Abelson murine leukemia viral oncogene homolog 1) | Turhan AG | http://atlasgeneticsoncology.org/Genes/ABLID1.html |
| Genes | ADAM12 (ADAM metallopeptidase domain 12 (meltrin alpha)) | Rocks N, Cataldo D | http://atlasgeneticsoncology.org/Genes/ADAM12ID44084ch10q26.html |
| Genes | ALDOB (aldolase B, fructose-bisphosphate) | Peng SY, Hsu HC | http://atlasgeneticsoncology.org/Genes/ALDOBID44287ch9q31.html |
| Genes | AR (Androgen Receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)) | D'Antonio J | http://atlasgeneticsoncology.org/Genes/ARID685chXq12.html |
| Genes | ASNS (asparagine synthetase) | Lorenzi PL, Ryan MC, Ikediobi ON, Weinstein JN | http://atlasgeneticsoncology.org/Genes/ASNSID44323ch7q21.html |
| Genes | AURKA (aurora kinase A) | Lentini L, Di Leonardo A | http://atlasgeneticsoncology.org/Genes/AURKAID730ch20q13.html |
| Genes | BAG1 (BCL2-associated athanogene) | Southern SL, Skeen V, Williams AC | http://atlasgeneticsoncology.org/Genes/BAG1ID742ch9p13.html |
| Genes | BCL2L11 (BCL2-like 11 (apoptosis facilitator)) | Giam M, Strasser A, Bouillet P | http://atlasgeneticsoncology.org/Genes/BCL2L11ID772ch2q13.html |
| Genes | BCL2L12 (BCL2-like 12 (proline-rich)) | Kontos C, Thomadaki H, Scorilas A | http://atlasgeneticsoncology.org/Genes/BCL2L12ID773ch19q13.html |
| Genes | BCL7B (B-cell CLL/lymphoma 7B) | Potter N | http://atlasgeneticsoncology.org/Genes/BCL7BID779ch7q11.html |
| Genes | BCR (Breakpoint cluster region) | Turhan AG | http://atlasgeneticsoncology.org/Genes/BCRID55.html |
| Genes | BIN1 (Bridging Integrator 1) | Chang MY, Prendergast GC | http://atlasgeneticsoncology.org/Genes/BIN1ID794ch2q14.html |
| Genes | BLCAP (bladder cancer associated protein) | Xinxing W, Min Z, Zehua Z | http://atlasgeneticsoncology.org/Genes/BLCAPID801ch20q11.html |
| Genes | BOP1 (block of proliferation 1) | Killian A, Sesboüé R | http://atlasgeneticsoncology.org/Genes/BOP1ID44348ch8q22.html |
| Genes | BRMS1 (breast cancer metastasis suppressor 1) | Buggy Y, Duffy MJ | http://atlasgeneticsoncology.org/Genes/BRMS1ID841ch11q13.html |
| Genes | BTK (Bruton agammaglobulinemia tyrosine kinase) | Hendriks RW, van Loo PF | http://atlasgeneticsoncology.org/Genes/BTKID851chXq22.html |
| Genes | BTRC (beta-transducin repeat containing) | Wang B | http://atlasgeneticsoncology.org/Genes/BTRCID451ch10q24.html |
| Genes | CAV1 (caveolin 1, caveolae protein, 22kDa) | Tanase C | http://atlasgeneticsoncology.org/Genes/CAV1ID932ch7q31.html |
| Genes | CD200 (CD200 molecule) | Mathews L, Farrar W | http://atlasgeneticsoncology.org/Genes/CD200ID44381ch3q13.html |
| Genes | CD248 (CD248 molecule, endosialin) | Becker R, Augustin HG | http://atlasgeneticsoncology.org/Genes/CD248ID968ch11q13.html |
| Genes | CDC20 (cell division cycle 20 homolog (S. cerevisiae)) | Roychoudhury S, Banerjee T, Nath S | http://atlasgeneticsoncology.org/Genes/CDC20ID40003ch1p34.html |
| Genes | CDC25A (Cell division cycle 25A) | Ray D, Kiyokawa H | http://atlasgeneticsoncology.org/Genes/CDC25AID40004ch3p21.html |
| Genes | CDC42 (cell division cycle 42 (GTP binding protein, 25kDa)) | Valdés-Mora F, Gómez del Pulgar T, Lacal JC | http://atlasgeneticsoncology.org/Genes/CDC42ID40012ch1p36.html |
| Genes | CDC6 (cell division cycle 6 homolog (S. cerevisiae)) | Zachariadis M, Gorgoulis VG | http://atlasgeneticsoncology.org/Genes/CDC6ID40014ch17q21.html |
| Genes | CDC73 (cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)) | Farber L, Teh BT | http://atlasgeneticsoncology.org/Genes/CDC73ID181ch1q31.html |
| Genes | CENPF (centromere protein F, 350/400ka (mitosin)) | Shigeishi H, Higashikawa K, Kamata N | http://atlasgeneticsoncology.org/Genes/CENPFID40057ch1q41.html |
| Genes | CFLAR (CASP8 and FADD-like apoptosis regulator) | Le Clorennec C, Longley DB, Wilson T | http://atlasgeneticsoncology.org/Genes/CFLARID40065ch2q33.html |
| Genes | CHKA (choline kinase alpha) | Ramírez de Molina A, Álvarez-Miranda M, Lacal JC | http://atlasgeneticsoncology.org/Genes/CHKAID44009ch11q13.html |
| Genes | COL1A2 (collagen, type I, alpha 2) | Perruccio EM, Roberts DD | http://atlasgeneticsoncology.org/Genes/COL1A2ID411ch7q22.html |
| Genes | CSF1R (colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog) | Fischer JA, Rossetti S, Sacchi N | http://atlasgeneticsoncology.org/Genes/CSF1RID40161ch5q32.html |
| Genes | CSNK1A1 (casein kinase 1, alpha 1) | Doerfel M, Huber O | http://atlasgeneticsoncology.org/Genes/CSNK1A1ID40168ch5q32.html |
| Genes | CSTA (cystatin A (stefin A)) | Jevnikar Z, Kos J | http://atlasgeneticsoncology.org/Genes/CSTAID40180ch3q21.html |
| Genes | CSTB (cystatin B (stefin B)) | Jevnikar Z, Kos J | http://atlasgeneticsoncology.org/Genes/CSTBID40181ch21q22.html |
| Genes | CTHRC1 (Collagen Triple Helix Repeat Containing 1) | LeClair R, Durmus T, Lindner V | http://atlasgeneticsoncology.org/Genes/CTHRC1ID40193ch8q22.html |
| Genes | CTSB (cathepsin B) | Jevnikar Z, Kos J | http://atlasgeneticsoncology.org/Genes/CTSBID40202ch8p23.html |
| Genes | CXCR3 (chemokine (C-X-C motif) receptor 3) | Taketo MM, Kawada K | http://atlasgeneticsoncology.org/Genes/CXCR3ID40224chXq13.html |
| Genes | DENR (density-regulated protein) | Reinert LS, Gartenhaus RB | http://atlasgeneticsoncology.org/Genes/DENRID40295ch12q24.html |
| Genes | DMTF1 (cyclin D binding myb-like transcription factor 1) | Inoue K | http://atlasgeneticsoncology.org/Genes/DMTF1ID40340ch7q21.html |
| Genes | DNMT1 (DNA (cytosine-5-)-methyltransferase 1)) | Arai E, Kanai Y | http://atlasgeneticsoncology.org/Genes/DNMT1ID40347ch19p13.html |
| Genes | DRAM1 (damage-regulated autophagy modulator) | Spinella MJ | http://atlasgeneticsoncology.org/Genes/DRAMID44093ch12q23.html |
| Genes | DYRK1B (dual-specificity tyrosine- (Y)-phosphorylation regulated kinase 1B) | Friedman E | http://atlasgeneticsoncology.org/Genes/DYRK1BID43235ch19q13.html |
| Genes | E2F1 (E2F transcription factor 1) | Zachariadis M, Gorgoulis VG | http://atlasgeneticsoncology.org/Genes/E2F1ID40382ch20q11.html |
| Genes | EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) | Noubir S, Lee JM | http://atlasgeneticsoncology.org/Genes/EEF1A2ID40408ch20q13.html |
| Genes | EGLN1 (egl nine homolog 1 (C. elegans)) | Jokilehto T, Jaakkola PM | http://atlasgeneticsoncology.org/Genes/EGLN1ID44140ch1q42.html |
| Genes | EIF3C (eukaryotic translation initiation factor 3, subunit C) | Scoles Daniel R | http://atlasgeneticsoncology.org/Genes/EIF3CID44187ch16p11.html |
| Genes | ELAC2 (elaC homolog 2 (E. coli)) | Chen Y, Tavtigian S, Shattuck D | http://atlasgeneticsoncology.org/Genes/ELAC2ID40437ch17p11.html |
| Genes | ELAVL1 (ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R)) | Dormoy-Raclet V, Gallouzi IE | http://atlasgeneticsoncology.org/Genes/ELAVL1ID44237ch19p13.html |
| Genes | ENAH (enabled homolog (Drosophila)) | Nisticò P, Di Modugno F | http://atlasgeneticsoncology.org/Genes/ENAHID44148ch1q42.html |
| Genes | EPB41L3 (erythrocyte membrane protein band 4.1-like 3) | Wong SY | http://atlasgeneticsoncology.org/Genes/EPB41L3ID40458ch18p11.html |
| Genes | EPCAM (tumor-associated calcium signal transducer 1) | Gires O | http://atlasgeneticsoncology.org/Genes/TACSTD1ID42459ch2p21.html |
| Genes | EPHA1 (EPH receptor A1) | Stringer B, Herath N, Duffy S, Coulthard M, Boyd A | http://atlasgeneticsoncology.org/Genes/EPHA1ID40461ch7q35.html |
| Genes | ERRFI1 (ERBB receptor feedback inhibitor 1) | Zhang YW | http://atlasgeneticsoncology.org/Genes/ERRFI1ID44147ch1p36.html |
| Genes | ESR2 (Estrogen Receptor 2 (ER beta)) | Zhao C, Dahlman-Wright K, Gustafsson JA | http://atlasgeneticsoncology.org/Genes/ESR2ID40500ch14q23.html |
| Genes | ETS2 (v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)) | Buggy Y, Duffy MJ | http://atlasgeneticsoncology.org/Genes/ETS2ID40503ch21q22.html |
| Genes | FBXO31 (F-box protein 31) | Bais AJ | http://atlasgeneticsoncology.org/Genes/FBXO31ID44280ch16q24.html |
| Genes | FGFR1 (Fibroblast Growth Factor Receptor 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/FGFR1ID113.html |
| Genes | FGFR2 (fibroblast growth factor receptor 2) | Katoh M | http://atlasgeneticsoncology.org/Genes/FGFR2ID40570ch10q26.html |
| Genes | FOXM1 (forkhead box M1) | Laoukili J, Alvarez Fernandez M, Medema RH | http://atlasgeneticsoncology.org/Genes/FOXM1ID40631ch12p13.html |
| Genes | FOXO1 (Forkhead box O1) | O'Connor R, Barr FG | http://atlasgeneticsoncology.org/Genes/FOXO1ID83ch13q14.html |
| Genes | FOXP3 (forkhead box P3) | Liu Y, Wang L | http://atlasgeneticsoncology.org/Genes/FOXP3ID44129chXp11.html |
| Genes | FSCN1 (fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)) | Nagai S, Smith CA, Mondal S, Rutka JT | http://atlasgeneticsoncology.org/Genes/FSCN1ID44342ch7p22.html |
| Genes | FXYD5 (FXYD domain containing ion transport regulator 5) | Hirohashi S | http://atlasgeneticsoncology.org/Genes/FXYD5ID40652ch19q13.html |
| Genes | GDF15 (growth differentiation factor 15) | Senapati S, Singh AP, Batra SK | http://atlasgeneticsoncology.org/Genes/GDF15ID40701ch19p13.html |
| Genes | GGH (gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) | Cheng Q, Evans WE | http://atlasgeneticsoncology.org/Genes/GGHID44358ch8q12.html |
| Genes | GPA33 (glycoprotein A33 (transmembrane)) | Tabone T, Heath JK | http://atlasgeneticsoncology.org/Genes/GPA33ID40735ch1q23.html |
| Genes | GPR68 (G protein-coupled receptor 68) | Xu Y | http://atlasgeneticsoncology.org/Genes/GPR68ID40745ch14q32.html |
| Genes | HFE (hemochromatosis) | Dorak MT | http://atlasgeneticsoncology.org/Genes/HFEID44099ch6p22.html |
| Genes | HSPG2 (heparan sulfate proteoglycan 2) | Farach-Carson MC, Grindel B | http://atlasgeneticsoncology.org/Genes/HSPG2ID40890ch1p36.html |
| Genes | ICAM1 (intercellular adhesion molecule 1 (CD54), human rhinovirus receptor) | Yashiro M | http://atlasgeneticsoncology.org/Genes/ICAM1ID40909ch19p13.html |
| Genes | ID4 (inhibitor of DNA binding 4, dominant negative helix-loop-helix protein) | Huret JL | http://atlasgeneticsoncology.org/Genes/ID4ID40916ch6p22.html |
| Genes | IGF1R (insulin-like growth factor 1 receptor) | Bentov Y, Werner H | http://atlasgeneticsoncology.org/Genes/IGF1RID40928ch15q26.html |
| Genes | IL1B (interleukin 1, beta) | Giraldo S, Sanchez J, Felty Q, Roy D | http://atlasgeneticsoncology.org/Genes/IL1BID40950ch2q13.html |
| Genes | IL21R (interleukin 21 receptor) | Ferrini S, Fabbi M | http://atlasgeneticsoncology.org/Genes/IL21RID40955ch16p12.html |
| Genes | IRF1 (interferon regulatory factor 1) | Palladinetti P, Symonds G, Dolnikov A | http://atlasgeneticsoncology.org/Genes/IRF1ID40990ch5q23.html |
| Genes | ITGA11 (integrin, alpha 11) | Popova SN, Gullberg D | http://atlasgeneticsoncology.org/Genes/ITGA11ID41001ch15q23.html |
| Genes | KCNH1 (potassium voltage-gated channel, subfamily H (eag-related), member 1) | Pardo LA | http://atlasgeneticsoncology.org/Genes/KCNH1ID41048ch1q32.html |
| Genes | KLF4 (Kruppel-like factor 4 (gut)) | Ghaleb AM, Yang VW | http://atlasgeneticsoncology.org/Genes/KLF4ID44316ch9q31.html |
| Genes | KLK11 (Kallikrein-related peptidase 11) | Luo LY, Diamandis EP | http://atlasgeneticsoncology.org/Genes/KLK11ID41077ch19q13.html |
| Genes | KLK5 (Kallikrein-related peptidase 5) | Yousef GM, Diamandis EP | http://atlasgeneticsoncology.org/Genes/KLK5ID41085ch19q13.html |
| Genes | L1CAM (L1 cell adhesion molecule) | Schäfer H, Sebens Müerköster S | http://atlasgeneticsoncology.org/Genes/L1CAMID44110chXq28.html |
| Genes | LOXL3 (lysyl oxidase-like 3) | Szauter KM, Csiszar K | http://atlasgeneticsoncology.org/Genes/LOXL3ID44000ch2p13.html |
| Genes | LYPD3 (LY6/PLAUR domain containing 3) | Jacobsen B, Ploug M | http://atlasgeneticsoncology.org/Genes/LYPD3ID44245ch19q13.html |
| Genes | MAPK4 (mitogen-activated protein kinase 4) | Meloche S | http://atlasgeneticsoncology.org/Genes/MAPK4ID41293ch18q21.html |
| Genes | MAPK6 (mitogen-activated protein kinase 6) | Meloche S | http://atlasgeneticsoncology.org/Genes/MAPK6ID43349ch15q21.html |
| Genes | MEG3 (maternally expressed 3) | Zhou Y | http://atlasgeneticsoncology.org/Genes/MEG3ID44393ch14q32.html |
| Genes | MERTK (c-mer proto-oncogene tyrosine kinase) | Keating AK, Linger RMA, Graham DK | http://atlasgeneticsoncology.org/Genes/MERTKID41339ch2q13.html |
| Genes | MIB2 (mindbomb homolog 2 (Drosophila)) | Takeuchi T | http://atlasgeneticsoncology.org/Genes/MIB2ID44179ch1p36.html |
| Genes | MIR10B (microRNA 10b) | Akman B, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN10BID44292ch2q31.html |
| Genes | MIR125A (microRNA 125a) | Tuna S, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN125AID44325ch19q13.html |
| Genes | MIR125B1 (microRNA 125b-1) | Tuna S, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN125B1ID44326ch11q24.html |
| Genes | MIR125B2 (microRNA 125b-2) | Tuna S, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN125B2ID44327ch21q21.html |
| Genes | MIR221 (microRNA 221) | Tabasi SA, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN221ID44277chXp11.html |
| Genes | MIR222 (microRNA 222) | Tabasi SA, Erson AE | http://atlasgeneticsoncology.org/Genes/MIRN222ID44278chXp11.html |
| Genes | MIR7-1 (microRNA 7-1) | Purow B | http://atlasgeneticsoncology.org/Genes/MIRN71ID44356ch9q21.html |
| Genes | MTOR (FK506 binding protein 12-rapamycin associated protein 1) | Altomare DA, Testa JR | http://atlasgeneticsoncology.org/Genes/FRAP1ID40639ch1p36.html |
| Genes | MTUS1 (mitochondrial tumor suppressor 1) | Zhou X, Yu J, Liu X | http://atlasgeneticsoncology.org/Genes/MTUS1ID41451ch8p22.html |
| Genes | MYBL2 (v-myb myeloblastosis viral oncogene homolog (avian)-like 2) | Chayka O, Sala A | http://atlasgeneticsoncology.org/Genes/MYBL2ID41469ch20q13.html |
| Genes | NBEAP1 (B-cell CLL/lymphoma 8) | Rasi S, Gaidano G | http://atlasgeneticsoncology.org/Genes/BCL8ID781ch15q11.html |
| Genes | NCOA4 (Nuclear Receptor Coactivator 4) | de Biase D, Morandi L, Tallini G | http://atlasgeneticsoncology.org/Genes/NCOA4ID218ch10q11.html |
| Genes | NECTIN4 (poliovirus receptor-related 4) | Lopez M | http://atlasgeneticsoncology.org/Genes/PVRL4ID44141ch1q23.html |
| Genes | NET1 (neuroepithelial cell transforming gene 1) | Murray D, Doran P | http://atlasgeneticsoncology.org/Genes/NET1ID41526ch10p15.html |
| Genes | NKX2-2 (NK2 homeobox 2) | Lessnick SL, Owen LA | http://atlasgeneticsoncology.org/Genes/NKX22ID44177ch20p11.html |
| Genes | NOP53 (ribosome biogenesis factor) | Maehama T | http://atlasgeneticsoncology.org/Genes/GLTSCR2ID40723ch19q13.html |
| Genes | NOTCH2 (Notch homolog 2 (Drosophila)) | Bigas A, Espinosa L | http://atlasgeneticsoncology.org/Genes/NOTCH2ID41556ch1p12.html |
| Genes | NR3C2 (nuclear receptor subfamily 3, group C, member 2) | Di Fabio F, Gottlieb B, Beitel LK, Trifiro M | http://atlasgeneticsoncology.org/Genes/NR3C2ID44262ch4q31.html |
| Genes | NRF1 (nuclear respiratory factor 1) | Roy D, Tamuli R | http://atlasgeneticsoncology.org/Genes/NRF1ID44233ch7q32.html |
| Genes | NSD2 (nuclear receptor binding SET domain protein 2 ) | Martinez-Garcia E, Licht JD | http://atlasgeneticsoncology.org/Genes/WHSC1ID42809ch4p16.html |
| Genes | P2RX7 (purinergic receptor P2X, ligand-gated ion channel, 7) | Pelegrin P, Surprenant A | http://atlasgeneticsoncology.org/Genes/P2RX7ID41623ch12q24.html |
| Genes | PAF1 (Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)) | Deb S, Ponnusamy MP, Batra SK | http://atlasgeneticsoncology.org/Genes/PAF1ID44202ch19q13.html |
| Genes | PDCD6 (programmed cell death 6) | Berchtold MW | http://atlasgeneticsoncology.org/Genes/PDCD6ID43402ch5p15.html |
| Genes | PKM (pyruvate kinase isoenzyme type M2) | Mazurek S, Hugo F, Zwerschke W | http://atlasgeneticsoncology.org/Genes/PKM2ID41728ch15q22.html |
| Genes | PLAGL2 (Pleomorphic adenoma gene-like 2) | Abdollahi A | http://atlasgeneticsoncology.org/Genes/PLAGL2ID41738ch20q11.html |
| Genes | PPARG (peroxisome proliferator-activated receptor gamma) | Astarci E, Banerjee S | http://atlasgeneticsoncology.org/Genes/PPARGID383ch3p25.html |
| Genes | PRDM2 (PR domain containing 2, with ZNF domain) | Di Zazzo E, Montcharmont B | http://atlasgeneticsoncology.org/Genes/PRDM2ID41834ch1p36.html |
| Genes | PRKCD (protein kinase C, delta) | Malavez Y, Gonzalez-Mejia ME, Doseff AI | http://atlasgeneticsoncology.org/Genes/PRKCDID42901ch3p21.html |
| Genes | PTCH2 (patched homolog 2 (Drosophila)) | Zaphiropoulos P | http://atlasgeneticsoncology.org/Genes/PTCH2ID41892ch1p34.html |
| Genes | PTPN13 (Protein tyrosine phosphatase, non-receptor type 13) | Beghini A | http://atlasgeneticsoncology.org/Genes/PTPN13ID41912ch4q21.html |
| Genes | PTPN21 (protein tyrosine phosphatase, non-receptor type 21) | Feliciello A | http://atlasgeneticsoncology.org/Genes/PTPN21ID41916ch14q21.html |
| Genes | PTTG1 (pituitary tumor-transforming 1) | Panguluri SK, Kakar SS | http://atlasgeneticsoncology.org/Genes/PTTG1ID41943ch5q35.html |
| Genes | PTTG1IP (pituitary tumor-transforming 1 interacting protein) | Smith V, McCabe C | http://atlasgeneticsoncology.org/Genes/PTTG1IPID41944ch21q22.html |
| Genes | RAC2 (ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)) | Gómez del Pulgar T, Lacal JC | http://atlasgeneticsoncology.org/Genes/RAC2ID42021ch22q13.html |
| Genes | RASGRF1 (Ras protein-specific guanine nucleotide-releasing factor 1) | Calvo F, Crespo P | http://atlasgeneticsoncology.org/Genes/RASGRF1ID43453ch15q25.html |
| Genes | RBBP8 (retinoblastoma binding protein 8) | Chinnadurai G, Subramanian T, Vijayalingam S | http://atlasgeneticsoncology.org/Genes/RBBP8ID42066ch18q11.html |
| Genes | RBX1 (ring-box 1) | Jia L, Sun Y | http://atlasgeneticsoncology.org/Genes/RBX1ID42075ch22q13.html |
| Genes | RHOBTB1 (Rho-related BTB domain containing 1) | Schenková K, Rivero F | http://atlasgeneticsoncology.org/Genes/RHOBTB1ID42981ch10q22.html |
| Genes | RHOBTB2 (Rho-related BTB domain containing 2) | Schenková K, Rivero F | http://atlasgeneticsoncology.org/Genes/RHOBTB2ID42109ch8p21.html |
| Genes | ROBO1 (roundabout, axon guidance receptor, homolog 1 (Drosophila)) | Doebler O, Groene J | http://atlasgeneticsoncology.org/Genes/ROBO1ID42140ch3p12.html |
| Genes | RPS6KA1 (ribosomal protein S6 kinase, 90kDa, polypeptide 1) | Roux P P | http://atlasgeneticsoncology.org/Genes/RPS6KA1ID43477ch1p36.html |
| Genes | RSF1 (remodeling and spacing factor 1) | Wang TL, Park JT | http://atlasgeneticsoncology.org/Genes/RSF1ID44107ch11q13.html |
| Genes | RSPO1 (R-spondin homolog (Xenopus laevis)) | Blaydon D | http://atlasgeneticsoncology.org/Genes/RSPO1ID44137ch1p34.html |
| Genes | S100A10 (S100 calcium binding protein A10) | Madureira PA, Waisman DM | http://atlasgeneticsoncology.org/Genes/S100A10ID44145ch1q21.html |
| Genes | S100A13 (S100 calcium binding protein A13) | Barone C, Bagalà C, Landriscina M | http://atlasgeneticsoncology.org/Genes/S100A13ID44197ch1q21.html |
| Genes | S100P (S100 calcium binding protein P) | Barry S, Crnogorac-Jurcevic T | http://atlasgeneticsoncology.org/Genes/S100PID42196ch4p16.html |
| Genes | SDC1 (syndecan 1) | Purushothaman A, Sanderson RD | http://atlasgeneticsoncology.org/Genes/SDC1ID42223ch2p24.html |
| Genes | SELE (selectin E, endothelial adhesion molecule 1) | Seidita G, De Leo G, Alessandro R | http://atlasgeneticsoncology.org/Genes/SELEID42247ch1q22.html |
| Genes | SEMA3F (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F) | Potiron VA, Drabkin HA, Roche J | http://atlasgeneticsoncology.org/Genes/SEMA3FID42254ch3p21.html |
| Genes | SEMA4D (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D) | Basile JR | http://atlasgeneticsoncology.org/Genes/SEMA4DID42255ch9q22.html |
| Genes | SMAP1 (stromal membrane-associated protein 1) | Tanabe K, Kon S, Satake M | http://atlasgeneticsoncology.org/Genes/SMAP1ID42974ch6q13.html |
| Genes | SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) | Medina PP, Sanchez-Cespedes M | http://atlasgeneticsoncology.org/Genes/SMARCA4ID42333ch19p13.html |
| Genes | SORBS2 (sorbin and SH3 domain containing 2) | Huret JL | http://atlasgeneticsoncology.org/Genes/SORBS2ID693ch4q35.html |
| Genes | SPP1 (secreted phosphoprotein 1) | Rodrigues LR | http://atlasgeneticsoncology.org/Genes/SPP1ID42379ch4q22.html |
| Genes | SSX2 (synovial sarcoma, X breakpoint 2) | Eid J, Garcia C, Frump A | http://atlasgeneticsoncology.org/Genes/SSX2ID42406chXp11.html |
| Genes | ST6GALNAC1 (ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1) | Delannoy P, Harduin-Lepers A, Krzewinski-Recchi MA | http://atlasgeneticsoncology.org/Genes/ST6GALNAC1ID44087ch17q25.html |
| Genes | STRN (striatin, calmodulin binding protein) | Huret JL | http://atlasgeneticsoncology.org/Genes/STRNID44243ch2p22.html |
| Genes | TACC1 (transforming, acidic coiled-coil containing protein 1) | Still I, Eslinger MR,Lauffart B | http://atlasgeneticsoncology.org/Genes/TACC1ID42456ch8p11.html |
| Genes | TCL1B (T-cell leukemia/lymphoma 1B) | Eradat H, Teitell MA | http://atlasgeneticsoncology.org/Genes/TCL1BID354ch14q32.html |
| Genes | TFRC (transferrin receptor (p90, CD71)) | Dorak MT | http://atlasgeneticsoncology.org/Genes/TFRCID259ch3q29.html |
| Genes | TGFBR3 (transforming growth factor, beta receptor III) | Gatza CE, Blobe GC | http://atlasgeneticsoncology.org/Genes/TGFBR3ID42541ch1p33.html |
| Genes | TIAM1 (T-cell lymphoma invasion and metastasis 1) | Hoffmann MJ, Engers R | http://atlasgeneticsoncology.org/Genes/TIAM1ID42557ch21q22.html |
| Genes | TIMP2 (TIMP metallopeptidase inhibitor 2) | Vynios DH | http://atlasgeneticsoncology.org/Genes/TIMP2ID42572ch17q25.html |
| Genes | TNC (tenascin C (hexabrachion)) | Degen M, Chiquet-Ehrismann R | http://atlasgeneticsoncology.org/Genes/TNCID42597ch9q33.html |
| Genes | TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) | Di Iasio MG, Corallini F, Secchiero P, Capitani S | http://atlasgeneticsoncology.org/Genes/TNFRSF11BID42610ch8q24.html |
| Genes | TNN (tenascin N) | Degen M, Chiquet-Ehrismann R | http://atlasgeneticsoncology.org/Genes/TNNID44209ch1q25.html |
| Genes | TSPAN1 (tetraspanin 1) | Murray D, Doran P | http://atlasgeneticsoncology.org/Genes/TSPAN1ID44178ch1p34.html |
| Genes | UBE2C (ubiquitin-conjugating enzyme E2C) | Pallate P, Berlingieri MT, Fusco A | http://atlasgeneticsoncology.org/Genes/UBE2CID44079ch20q13.html |
| Genes | UBE3A (ubiquitin protein ligase E3A) | Matentzoglu K, Scheffner M | http://atlasgeneticsoncology.org/Genes/UBE3AID42756ch15q11.html |
| Genes | USP7 (ubiquitin specific peptidase 7 (herpes virus-associated)) | Baek KH, Ramakrishna S | http://atlasgeneticsoncology.org/Genes/USP7ID42773ch16p13.html |
| Genes | VTCN1 (V-set domain containing T cell activation inhibitor 1) | Samarawardana P, Shroyer KR | http://atlasgeneticsoncology.org/Genes/VTCN1ID44144ch1p13.html |
| Genes | WDR77 (WD repeat domain 77) | Daniels G, Wang Z, Lee P | http://atlasgeneticsoncology.org/Genes/WDR77ID44142ch1p13.html |
| Genes | WNT5A (wingless-type MMTV integration site family, member 5A) | Katoh M | http://atlasgeneticsoncology.org/Genes/WNT5AID42825ch3p14.html |
| Genes | WWP1 (WW domain containing E3 ubiquitin protein ligase 1) | Chen C | http://atlasgeneticsoncology.org/Genes/WWP1ID42993ch8q21.html |
| Genes | XAF1 (XIAP associated factor-1) | Plenchette S, Fong WG, Korneluk RG | http://atlasgeneticsoncology.org/Genes/XAF1ID44095ch17p13.html |
| Leukemias | Atypical Chronic Myeloid Leukemia (aCML) | Hernandez JM, Villaescusa T, Arefi M, López L, Garcia JL | http://atlasgeneticsoncology.org/Anomalies/aCMLID2117.html |
| Leukemias | Chronic myelogenous leukaemia (CML) | Turhan AG | http://atlasgeneticsoncology.org/Anomalies/CMLID1117.html |
| Leukemias | Hepatosplenic T-cell lymphoma (HSTCL) | Cuneo A, Cavazzini F, Rigolin GM | http://atlasgeneticsoncology.org/Anomalies/HepatoTlymphoID2099.html |
| Leukemias | Intestinal T-cell lymphoma | Cuneo A, Cavazzini F, Rigolin GM | http://atlasgeneticsoncology.org/Anomalies/IntestinalTlymphoID2101.html |
| Leukemias | Isolated tetrasomy 8 in AML, MDS and MPD | Theisen O, Lai JL, Nibourel O, Roche-Lestienne C | http://atlasgeneticsoncology.org/Anomalies/Tetra8ID1517.html |
| Leukemias | Nasal T cell lymphoma (published in 2008) | Cuneo A, Cavazzini F, Rigolin GM | http://atlasgeneticsoncology.org/Anomalies/NasalTCellLymphomID2100.html |
| Leukemias | dic(17;20)(p11.2;q11.2) | Meloni-Ehrig AM | http://atlasgeneticsoncology.org/Anomalies/dic1720p11q11ID1485.html |
| Leukemias | i(6)(p10) | Gallego MS | http://atlasgeneticsoncology.org/Anomalies/i6p10ID1053.html |
| Leukemias | ider(20q) in Myeloid Malignancies | Douet-Guilbert N, Laï JL, Andrieux J, Basinko A, Le Bris MJ, Morel F, De Braekeleer M | http://atlasgeneticsoncology.org/Anomalies/ider20qMMID1481.html |
| Leukemias | inv(18)(p11q21) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv18p11q21ID1545.html |
| Leukemias | inv(19)(p13q13) TCF3/TFPT | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1919p13q13ID1295.html |
| Leukemias | inv(6)(p25q13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv06p15q13ID1529.html |
| Leukemias | t(10;11)(q22;q23) KMT2A/TET1 | Viguié F | http://atlasgeneticsoncology.org/Anomalies/t1011q22q23ID1410.html |
| Leukemias | t(10;12)(q24;p13) ETV6/GOT1 | Wlodarska I | http://atlasgeneticsoncology.org/Anomalies/t1012q24p13ID1451.html |
| Leukemias | t(11;17)(p15;p13) NUP98/PHF23 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1117p15p13ID2134.html |
| Leukemias | t(12;15)(p13;q25) ETV6/NTRK3 in Hematological malignancies | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1215p13q25ID1347.html |
| Leukemias | t(12;17)(p13;p13) ETV6/PER1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1217p13p13ID1348.html |
| Leukemias | t(12;21)(q12;q22) RUNX1 truncated | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1221q12q22ID1339.html |
| Leukemias | t(14;14)(q11;q32) CEBPE/IGH | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1414q11q32CEBPEIGHID1438.html |
| Leukemias | t(14;15)(q32;q11) IGH/NBEAP1 | Rasi S, Gaidano G | http://atlasgeneticsoncology.org/Anomalies/t1415q32q12ID1349.html |
| Leukemias | t(14;18)(q32;q21) IGH/MALT1 | Streubel B | http://atlasgeneticsoncology.org/Anomalies/t1418q32q21ID1350.html |
| Leukemias | t(14;19)(q32;q13) IGH/CEBPA | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1419q32q13ALLID1335.html |
| Leukemias | t(14;20)(q32;q13) IGH/CEBPB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1420q32q13CEBPBIGHID1439.html |
| Leukemias | t(14;22)(q32;q11) IGH/IGL | Aamot HV, Delabie J | http://atlasgeneticsoncology.org/Anomalies/t1422q32q11ID1076.html |
| Leukemias | t(1;12)(q21;q24) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0112q21q24ID1531.html |
| Leukemias | t(1;6)(p36;p21) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0106p36p21ID1530.html |
| Leukemias | t(1;8)(p22-p32;q22-q23) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0108p31q22ID1207.html |
| Leukemias | t(20;21)(q11;q22) RUNX1/NOL4L | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t2021q11q22ID1307.html |
| Leukemias | t(2;19)(p12;q13.3) IGK/BCL3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1419ID2050.html |
| Leukemias | t(2;4)(p22;q12) STRN/PDGFRA | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0204p22q12ID2136.html |
| Leukemias | t(3;16)(q21;q22) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0316q21q22ID1088.html |
| Leukemias | t(3;21)(p12;q22) RUNX1/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0321p12q22ID1524.html |
| Leukemias | t(3;7)(q27;q32) MIR29A/BCL6 | Schneider B, Nagel S, Macleod RAF | http://atlasgeneticsoncology.org/Anomalies/t0307q27q32ID1515.html |
| Leukemias | t(3;8)(q21;q24) in myeloid malignancies | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0308q21q24ID1249.html |
| Leukemias | t(3;8)(q27;q24) BCL6/MYC | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0308q27q24ID2015.html |
| Leukemias | t(4;10)(q12;p11) KIF5B/PDGFRA | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0410q12p11ID1440.html |
| Leukemias | t(4;11)(p12;q23) KMT2A/FRYL | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0411p12q23ID1405.html |
| Leukemias | t(4;12)(q12;p13) PDGFRA/ETV6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0412q12p13ID2137.html |
| Leukemias | t(4;21)(q35;q22) RUNX1/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0421q35q22ID1525.html |
| Leukemias | t(4;5)(q31;q31) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0405q31q31ID1206.html |
| Leukemias | t(5;14)(q35;q32.2) BCL11B/TLX3 and NKX2-5 | Nagel S, MacLeod RAF | http://atlasgeneticsoncology.org/Anomalies/t0514q35q32ID1386.html |
| Leukemias | t(5;16)(q33;q22) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0516q33q22ID1151.html |
| Leukemias | t(5;17)(q33;p13) RABEP1/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0517q33p13ID1328.html |
| Leukemias | t(6;14)(p22;q32) IGH/ID4 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0614p22q32ID1480.html |
| Leukemias | t(6;14)(q25-27;q32) BCL11B/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0614q25q32ID1324.html |
| Leukemias | t(7;14)(q21;q13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0714q21q13ID1484.html |
| Leukemias | t(7;21)(p15;q22) RUNX1/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0721p15q22ID1526.html |
| Leukemias | t(8;11)(p12;p15) ?/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0811p12p15ID1521.html |
| Leukemias | t(8;12)(p12;q15) CPSF6/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0812p12q15ID1201.html |
| Leukemias | t(8;12)(q12;p13) | Gallego MS | http://atlasgeneticsoncology.org/Anomalies/t0812q12p13ID1218.html |
| Leukemias | t(8;14)(q11;q32) IGH/CEBPD | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0814ID1112.html |
| Leukemias | t(8;17)(p11;q25) ?/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0817p12q25ID1202.html |
| Leukemias | t(8;19)(p11;q13) ERVK-6/FGFR1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0819p12q13ID1203.html |
| Leukemias | t(8;21)(q23;q22) RUNX1/ZFPM2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0821q23q22ID1271.html |
| Leukemias | t(9;21)(q34;q22) RUNX1 truncated | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0921q34q22ID1483.html |
| Leukemias | t(X;21)(p11;q22) RUNX1/? | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X21p11q22ID1523.html |
| Leukemias | t(X;21)(q26;q22) ELF4/ERG | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Bone: Angiosarcoma | Verbeke SLJ, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Bone: Conventional Osteosarcoma | Mohseny AB | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Bone: Enchondroma | Pansuriya TC, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Bone: Haemangiomas and related lesions | Verbeke SLJ, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Bone: Osteochondroma | Reijnders C, Hameetman L, Bovée JVMG | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Gallbladder: Intrahepatic cholangiocarcinoma | Enjoji M, Aishima S | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Gastric Tumors: an overview | Lochhead P, El-Omar E | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Head and Neck: Laryngeal tumors: an overview | Mastronikolis NS, Papadas TA, Goumas PD, Triantaphyllidou IE, Theocharis DA, Papageorgakopoulou N, Vynios DH | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Kidney: Papillary adenoma | Eisengart LJ, Yang XJ | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Kidney: Renal Oncocytoma | Kim HJ, Monzon FA | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Liver tumors: an overview | Enjoji M | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Liver: Mesenchymal hamartoma with t(11;19)(q11;q13) MALAT1/MHLB1 | Knezevich S | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Lung: Non-small cell carcinoma with inv(2)(p21p23) EML4/ALK | Mano H | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Lymphangioleiomyomatosis | Taveira-DaSilva AM, Steagall WK, Moss J | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Nervous System: Glioma: an overview | Magnani I | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Nervous System: Optic nerve glioma | Niazi T, Walker ML | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Neuro-Endocrine/Endocrine system: Carcinoid tumors | Cayo M, Greenblatt DY, Kunnimalaiyaan M, Chen H | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Ovary: Choriocarcinoma | Yamamoto E | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Penile tumors: an overview | Blick C, Arya M, Patel N, Minhas S, Muneer A | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Solid Tumors | Soft Tissues: Dermatofibrosarcoma Protuberans | Patel K, Lopez-Terrada D | http://atlasgeneticsoncology.org/Anomalies/t0X21q26q22ID1442.html |
| Cancer-Prones | Alport syndrome and diffuse leiomyomatosis | Ayadi L, Abbes K, Makni S, Kharrat M, Kallel R, Affes N, Hmida MB, Hachicha J, Beyrouti MI, Boudawara TS | http://atlasgeneticsoncology.org/Kprones/AlportLeiomyoID10134.html |
| Cancer-Prones | Carney triad | Carney JA, Stratakis CA | http://atlasgeneticsoncology.org/Kprones/CarneyTriadID10132.html |
| Cancer-Prones | Enchondromatosis | Pansuriya TC, Bovée JVMG | http://atlasgeneticsoncology.org/Kprones/EnchondromatosisID10151.html |
| Cancer-Prones | Familial platelet disorder with predisposition to acute myelogenous leukemia | Heller PG | http://atlasgeneticsoncology.org/Kprones/FamPlateletDisAMLID10079.html |
| Cancer-Prones | Hereditary multiple cutaneous leiomyomatosis | Badeloe S, Frank J | http://atlasgeneticsoncology.org/Kprones/HeredMultCutLeiomyoID10127.html |
| Cancer-Prones | Hereditary prostate cancer | Schleutker J | http://atlasgeneticsoncology.org/Kprones/HeredProstateCancerID10055.html |
| Cancer-Prones | Klippel Trenaunay syndrome | Phadke SR | http://atlasgeneticsoncology.org/Kprones/KlippelTrenauneyID10144.html |
| Cancer-Prones | Maffucci syndrome | Pansuriya TC, Bovée JVMG | http://atlasgeneticsoncology.org/Kprones/MaffucciID10153.html |
| Cancer-Prones | McCune Albright syndrome | Zacharin M | http://atlasgeneticsoncology.org/Kprones/McCuneAlbrightID10093.html |
| Cancer-Prones | Multiple osteochondromas (MO) | Reijnders CMA, Bovée JVMG | http://atlasgeneticsoncology.org/Kprones/HeredMultExostosID10061.html |
| Cancer-Prones | Multiple self-healing squamous epithelioma | Goudie DR, D'Alessandro M | http://atlasgeneticsoncology.org/Kprones/MultSelfSquamEpithID10041.html |
| Cancer-Prones | Ollier disease | Pansuriya TC, Bovée JVMG | http://atlasgeneticsoncology.org/Kprones/OllierID10152.html |
| Cancer-Prones | Porokeratosis of Mibelli | Torchia D | http://atlasgeneticsoncology.org/Kprones/PorokeratosisMibelliID10106.html |
| Cancer-Prones | Prader Willi syndrome | Piccione M, Corsello G | http://atlasgeneticsoncology.org/Kprones/PraderWilliID10114.html |
| Cancer-Prones | Proteus syndrome | Choyke PL, Biesecker LG | http://atlasgeneticsoncology.org/Kprones/ProteusID10145.html |
| Cancer-Prones | Silver Russell syndrome | Piccione M, Corsello G | http://atlasgeneticsoncology.org/Kprones/SilverRussellID10149.html |
| Deep Insights | JAK2 mutations in myeloproliferative neoplasms | Gangat N, Tefferi A | http://atlasgeneticsoncology.org/Deep/JAK2mutationID20065.html |
| Deep Insights | RET point mutations in Thyroid Carcinoma | Elisei R, Romei C, Cosci B, Molinaro E, Agate L, Bottici V, Pinchera A | http://atlasgeneticsoncology.org/Deep/RETPointMutID20066.html |
| Deep Insights | Roles of tetraspanin proteins in cell and tumor biology | Lazo PA | http://atlasgeneticsoncology.org/Deep/TetraspaninID20062.html |
| Deep Insights | The HLA-G non classical MHC class I molecule is expressed in cancer with poor prognosis. Implications in tumour escape from immune system and clinical applications | Menier C, Rouas-Freiss N, Carosella ED | http://atlasgeneticsoncology.org/Deep/HLAinCancerID20070.html |
| Educational Items | Amino Acids (reminder) | Huret JL | http://atlasgeneticsoncology.org/Educ/AminoAcidsEngID30066ES.html |
| Educational Items | Chromosomes, Leukemias, Solid Tumors, Hereditary Cancers | Huret JL | http://atlasgeneticsoncology.org/Educ/Hempat_e.html |
| Educational Items | Chromosomes, leucémies, tumeurs, cancers héréditaires | Huret JL | http://atlasgeneticsoncology.org/Educ/Hempat_t.html |
| Educational Items | Enfermedades Malignas de la Sangre | Huret JL | http://atlasgeneticsoncology.org/Educ/HempatID30050SL.html |
| Educational Items | Evolution | Kalmes R | http://atlasgeneticsoncology.org/Educ/EvolutionID30026ES.html |
| Educational Items | Evolution | Kalmes R | http://atlasgeneticsoncology.org/Educ/EvolutionID30026FS.html |
| Educational Items | Gènes de la globine; drépanocytose - thalassémies | Huret JL, Troussard X | http://atlasgeneticsoncology.org/Educ/GenHemoglobID30014FS.html |
| Educational Items | Hemoglobin genes; Sickle-cell anemia - Thalassemias | Huret JL, Troussard X | http://atlasgeneticsoncology.org/Educ/GenHemoglobID30014ES.html |
| Educational Items | Nomenclature for the description of mutations and other sequence variations | Huret JL | http://atlasgeneticsoncology.org/Educ/NomMutID30067ES.html |
| Educational Items | Nomenclature pour la description des mutations et autres variations de séquence | Huret JL | http://atlasgeneticsoncology.org/Educ/NomMutID30067FS.html |
| Educational Items | Ultrastructure du chromosome | Dupont JM | http://atlasgeneticsoncology.org/Educ/StrucChromID30063FS.html |
